Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Diabetes

Free Subscription Articles published in Diabetes Obes Metab Retrieve available abstracts of 100 articles: HTML format Text format

Single Articles

March 2010
1. MORITOH Y , Takeuchi K, Hazama M
   Combination treatment with alogliptin and voglibose increases active GLP-1 circulation, prevents the development of diabetes and preserves pancreatic beta-cells in prediabetic db/db mice.
   Diabetes Obes Metab. 2010;12:224-33.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. CONARD S , Bays H, Leiter LA, Bird S, et al
   Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither.
   Diabetes Obes Metab. 2010;12:210-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. ELHAYANY A , Lustman A, Abel R, Attal-Singer J, et al
   A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study.
   Diabetes Obes Metab. 2010;12:204-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. FUJIOKA K
   Benefits of moderate weight loss in patients with type 2 diabetes.
   Diabetes Obes Metab. 2010;12:186-94.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
5. BLONDE L , Russell-Jones D
   The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies.
   Diabetes Obes Metab. 2009;11 Suppl 3:26-34.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. SESTI G
   Harnessing the weight-regulating properties of glucagon-like peptide-1 in the treatment of type 2 diabetes.
   Diabetes Obes Metab. 2009;11 Suppl 3:4-10.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. ZINMAN B
   The clinical challenges of managing type 2 diabetes and the potential of GLP-1-based therapies.
   Diabetes Obes Metab. 2009;11 Suppl 3:1-3.
   PubMed     Text format     Related articles   
   
   
   November 2009
8. ASCHNER P , Katzeff HL, Guo H, Sunga S, et al
   Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes.
   Diabetes Obes Metab. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. MUDALIAR S , Chang AR, Aroda VR, Chao E, et al
   Effects of intensive insulin therapy alone and with added pioglitazone on renal salt/water balance and fluid compartment shifts in type 2 diabetes.
   Diabetes Obes Metab. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. GRILL V , Radtke M, Qvigstad E, Kollind M, et al
    Beneficial effects of K-ATP channel openers in diabetes: an update on mechanisms and clinical experiences.
    Diabetes Obes Metab. 2009;11 Suppl 4:143-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. KOLFSCHOTEN IG , Roggli E, Nesca V, Regazzi R, et al
    Role and therapeutic potential of microRNAs in diabetes.
    Diabetes Obes Metab. 2009;11 Suppl 4:118-29.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. WEIR GC , Marselli L, Marchetti P, Katsuta H, et al
    Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes.
    Diabetes Obes Metab. 2009;11 Suppl 4:82-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. JONAS JC , Bensellam M, Duprez J, Elouil H, et al
    Glucose regulation of islet stress responses and beta-cell failure in type 2 diabetes.
    Diabetes Obes Metab. 2009;11 Suppl 4:65-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. TALCHAI C , Lin HV, Kitamura T, Accili D, et al
    Genetic and biochemical pathways of beta-cell failure in type 2 diabetes.
    Diabetes Obes Metab. 2009;11 Suppl 4:38-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. ROLLA AR
    What about insulin as an immediate first step for type 2 diabetes?
    Diabetes Obes Metab. 2009;11 Suppl 5:19-22.
    PubMed     Text format     Related articles   
    
    
    
16. GARBER AJ
    Insulin intensification strategies in type 2 diabetes: when one injection is no longer sufficient.
    Diabetes Obes Metab. 2009;11 Suppl 5:14-8.
    PubMed     Text format     Related articles   
    
    
    
17. GARBER AJ
    The importance of titrating starting insulin regimens in patients with type 2 diabetes.
    Diabetes Obes Metab. 2009;11 Suppl 5:10-3.
    PubMed     Text format     Related articles   
    
    
    
18. GARBER AJ
    Restaging insulin therapy for patients with type 2 diabetes.
    Diabetes Obes Metab. 2009;11 Suppl 5:1-5.
    PubMed     Text format     Related articles   
    
    
    
19. 
    Perspectives in type 2 diabetes: incorporating the latest insulin analogue strategies to achieve treatment success.
    Diabetes Obes Metab. 2009;11 Suppl 5:iii-iv.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
20. LUZIO SD , Dunseath G, Lockett A, Broke-Smith TP, et al
    The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. KIM C
    Managing women with gestational diabetes mellitus in the postnatal period.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. GALLWITZ B , Haring HU
    Future perspectives for insulinotropic agents in the treatment of type 2 diabetes-DPP-4 inhibitors and sulphonylureas.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. JARVIS J , Skinner TC, Carey ME, Davies MJ, et al
    How can structured self-management patient education improve outcomes in people with type 2 diabetes?
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. GAMBLE JM , Simpson SH, Eurich DT, Majumdar SR, et al
    Insulin use and increased risk of mortality in type 2 diabetes: a cohort study.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. KONDO K , Kadowaki T
    Colestilan monotherapy significantly improves glycaemic control and LDL cholesterol levels in patients with type 2 diabetes: a randomized double-blind placebo-controlled study.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. DEROSA G , Tinelli C, Maffioli P
    Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. ROSENSTOCK J , Rendell MS, Gross JL, Fleck PR, et al
    Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA without causing weight gain or increased hypoglycaemia.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. VAN GAAL LF , Caterson ID, Coutinho W, Finer N, et al
    Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. KAZDA C , Gallwitz B, Simo R, Guzman JR, et al
    The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. LIEBL A , Hoogma R, Renard E, Geelhoed-Duijvestijn PH, et al
    A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. RETNAKARAN R , Yakubovich N, Qi Y, Opsteen C, et al
    The response to short-term intensive insulin therapy in type 2 diabetes.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. MITTENDORF T , Smith-Palmer J, Timlin L, Happich M, et al
    Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. MOGENSEN M , Vind BF, Hojlund K, Beck-Nielsen H, et al
    Maximal lipid oxidation in patients with type 2 diabetes is normal and shows an adequate increase in response to aerobic training.
    Diabetes Obes Metab. 2009;11:874-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. TOMASSINI JE , Mazzone T, Goldberg RB, Guyton JR, et al
    Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia.
    Diabetes Obes Metab. 2009;11:855-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. SIMONSEN L , Pilgaard S, Orskov C, Hartmann B, et al
    Long-term exendin-4 treatment delays natural deterioration of glycaemic control in diabetic Goto-Kakizaki rats.
    Diabetes Obes Metab. 2009;11:884-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
36. BRAND CL , Galsgaard ED, Tornehave D, Romer J, et al
    Synergistic effect of the human GLP-1 analogue liraglutide and a dual PPARalpha/gamma agonist on glycaemic control in Zucker diabetic fatty rats.
    Diabetes Obes Metab. 2009;11:795-803.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. KALAITZIDIS R , Bakris G
    Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockers.
    Diabetes Obes Metab. 2009;11:757-69.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. IDRIS I , Hall AP, O'Reilly J, Barnett A, et al
    Obstructive sleep apnoea in patients with type 2 diabetes: aetiology and implications for clinical care.
    Diabetes Obes Metab. 2009;11:733-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. MOURAD C , Chevalier S, Morais JA, Lamarche M, et al
    Antihyperglycaemic medication modifies factors of postprandial satiety in type 2 diabetes.
    Diabetes Obes Metab. 2009;11:819-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. HEISE T , Graefe-Mody EU, Huttner S, Ring A, et al
    Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients.
    Diabetes Obes Metab. 2009;11:786-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. SCHWEIZER A , Dejager S, Bosi E
    Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial.
    Diabetes Obes Metab. 2009;11:804-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. WENTZEL P
    Can we prevent diabetic birth defects with micronutrients?
    Diabetes Obes Metab. 2009;11:770-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. KANAZU S , Horie Y, Narukawa M, Nonaka K, et al
    Predicting steady-state HbA1c responses to sitagliptin in patients with type 2 diabetes mellitus.
    Diabetes Obes Metab. 2009;11:813-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
44. MCAINCH AJ , Cameron-Smith D
    Adiponectin decreases pyruvate dehydrogenase kinase 4 gene expression in obese- and diabetic-derived myotubes.
    Diabetes Obes Metab. 2009;11:721-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. LLOYD DJ , Helmering J, Cordover D, Bowsman M, et al
    Antidiabetic effects of 11beta-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis.
    Diabetes Obes Metab. 2009;11:688-99.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. DASHORA U , Ashwell SG, Home PD
    An exploratory study of the effect of using high-mix biphasic insulin aspart in people with type 2 diabetes.
    Diabetes Obes Metab. 2009;11:680-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. CUCINOTTA D , Smirnova O, Christiansen JS, Kanc K, et al
    Three different premixed combinations of biphasic insulin aspart - comparison of the efficacy and safety in a randomized controlled clinical trial in subjects with type 2 diabetes.
    Diabetes Obes Metab. 2009;11:700-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. CHOUSSEIN S , Makri AA, Frangos CC, Petridou ET, et al
    Effect of antiobesity medications in patients with type 2 diabetes mellitus.
    Diabetes Obes Metab. 2009;11:641-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
49. BERTRAM HC , Jeppesen PB, Hermansen K
    An NMR-based metabonomic investigation on effects of supplementation with isosteviol or soy protein to diabetic KKAy mice.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles   
    
    
    
50. LUND SS , Tarnow L, Astrup AS, Hovind P, et al
    Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. POLISENA J , Tran K, Cimon K, Hutton B, et al
    Home telehealth for diabetes management: a systematic review and meta-analysis.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. YOUNIS N , Williams S, Soran H
    Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. JADZINSKY M , Pfutzner A, Paz-Pacheco E, Xu Z, et al
    Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial.
    Diabetes Obes Metab. 2009;11:611-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. BOLLI G , Dotta F, Colin L, Minic B, et al
    Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin.
    Diabetes Obes Metab. 2009;11:589-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. ROSENSTOCK J , Niggli M, Maldonado-Lutomirsky M
    Long-term 2-year safety and efficacy of vildagliptin compared with rosiglitazone in drug-naive patients with type 2 diabetes mellitus.
    Diabetes Obes Metab. 2009;11:571-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. TAN KC
    Reverse cholesterol transport in type 2 diabetes mellitus.
    Diabetes Obes Metab. 2009;11:534-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
57. THROWER SL , Bingley PJ
    Strategies to prevent type 1 diabetes.
    Diabetes Obes Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. HOHBERG C , Pfutzner A, Forst T, Lubben G, et al
    Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual beta-cell function: results from the PioSwitch study.
    Diabetes Obes Metab. 2009;11:464-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. STRACHAN MW , Reynolds RM, Frier BM, Mitchell RJ, et al
    The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes. Implications for future therapeutic strategies.
    Diabetes Obes Metab. 2009;11:407-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. BOSI E
    Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
    Diabetes Obes Metab. 2009;11 Suppl 2:3-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. SCHERBAUM WA
    Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.
    Diabetes Obes Metab. 2009;11 Suppl 2:1-2.
    PubMed     Text format     Related articles   
    
    
    
62. BOSI E , Dotta F, Jia Y, Goodman M, et al
    Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus.
    Diabetes Obes Metab. 2009;11:506-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. BELL DS
    Treatment of diabetic hypertension.
    Diabetes Obes Metab. 2009;11:433-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. YAO XM , Ye SD, Chen Y, Zai ZM, et al
    Rosiglitazone protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression.
    Diabetes Obes Metab. 2009;11:519-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. STARGARDT T , Yin DD, Alexander CM
    Treatment choice and effectiveness of adding sulphonylurea or glitazones to metformin for the treatment of type 2 diabetes mellitus.
    Diabetes Obes Metab. 2009;11:491-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. RAJPATHAK SN , Wylie-Rosett J, Gunter MJ, Negassa A, et al
    Biomarkers of body iron stores and risk of developing type 2 diabetes.
    Diabetes Obes Metab. 2009;11:472-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. VAN AVENDONK MJ , Rutten GE
    Insulin therapy in type 2 diabetes: what is the evidence?
    Diabetes Obes Metab. 2009;11:415-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. BARNETT AH
    Translating science into clinical practice: focus on vildagliptin in combination with metformin.
    Diabetes Obes Metab. 2009;11 Suppl 2:18-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. MATHIEU C
    The scientific evidence: vildagliptin and the benefits of islet enhancement.
    Diabetes Obes Metab. 2009;11 Suppl 2:9-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
70. MONAMI M , Marchionni N, Mannucci E
    Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis.
    Diabetes Obes Metab. 2009;11:372-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. RABOL R , Hojberg PM, Almdal T, Boushel R, et al
    Improved glycaemic control decreases inner mitochondrial membrane leak in type 2 diabetes.
    Diabetes Obes Metab. 2009;11:355-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. GUPTA AK , Smith SR, Greenway FL, Bray GA, et al
    Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome.
    Diabetes Obes Metab. 2009;11:330-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. AAS AM , Ohrvik J, Malmberg K, Ryden L, et al
    Insulin-induced weight gain and cardiovascular events in patients with type 2 diabetes. A report from the DIGAMI 2 study.
    Diabetes Obes Metab. 2009;11:323-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. LOVAS K , Rost TH, Skorve J, Ulvik RJ, et al
    Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation.
    Diabetes Obes Metab. 2009;11:304-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. JACOB S , Rabbia M, Meier MK, Hauptman J, et al
    Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss.
    Diabetes Obes Metab. 2009;11:361-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. YUSOF BN , Talib RA, Kamaruddin NA, Karim NA, et al
    A low-GI diet is associated with a short-term improvement of glycaemic control in Asian patients with type 2 diabetes.
    Diabetes Obes Metab. 2009;11:387-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
77. ERIKSTRUP C , Mortensen OH, Nielsen AR, Fischer CP, et al
    RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes.
    Diabetes Obes Metab. 2009;11:204-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
78. RICH SS , Akolkar B, Concannon P, Erlich H, et al
    Results of the MHC fine mapping workshop.
    Diabetes Obes Metab. 2009;11 Suppl 1:108-9.
    PubMed     Text format     Related articles   
    
    
    
79. JAMES I , McKinnon E, Gaudieri S, Morahan G, et al
    Missingness in the T1DGC MHC fine-mapping SNP data: association with HLA genotype and potential influence on genetic association studies.
    Diabetes Obes Metab. 2009;11 Suppl 1:101-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. MCKINNON E , Morahan G, Nolan D, James I, et al
    Association of MHC SNP genotype with susceptibility to type 1 diabetes: a modified survival approach.
    Diabetes Obes Metab. 2009;11 Suppl 1:92-100.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. BADENHOOP K , Kahles H, Seidl C, Kordonouri O, et al
    MHC-environment interactions leading to type 1 diabetes: feasibility of an analysis of HLA DR-DQ alleles in relation to manifestation periods and dates of birth.
    Diabetes Obes Metab. 2009;11 Suppl 1:88-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. KAHLES H , Kordonouri O, Ramos Lopez E, Walter M, et al
    Mating in parents of type 1 diabetes families as a function of the HLA DR-DQ haplotype.
    Diabetes Obes Metab. 2009;11 Suppl 1:84-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. BRONSON PG , Ramsay PP, Thomson G, Barcellos LF, et al
    Analysis of maternal-offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetes.
    Diabetes Obes Metab. 2009;11 Suppl 1:74-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. MORAHAN G , Mehta M, McKinnon E, James I, et al
    Effect of linkage status of affected sib-pairs on the search for novel type 1 diabetes susceptibility genes in the HLA complex.
    Diabetes Obes Metab. 2009;11 Suppl 1:67-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. BRORSSON C , Hansen NT, Lage K, Bergholdt R, et al
    Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data.
    Diabetes Obes Metab. 2009;11 Suppl 1:60-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. HE C , Hamon S, Li D, Barral-Rodriguez S, et al
    MHC fine mapping of human type 1 diabetes using the T1DGC data.
    Diabetes Obes Metab. 2009;11 Suppl 1:53-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. VALDES AM , Thomson G
    Several loci in the HLA class III region are associated with T1D risk after adjusting for DRB1-DQB1.
    Diabetes Obes Metab. 2009;11 Suppl 1:46-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. HOWSON JM , Walker NM, Clayton D, Todd JA, et al
    Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A.
    Diabetes Obes Metab. 2009;11 Suppl 1:31-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. BASCHAL EE , Aly TA, Jasinski JM, Steck AK, et al
    The frequent and conserved DR3-B8-A1 extended haplotype confers less diabetes risk than other DR3 haplotypes.
    Diabetes Obes Metab. 2009;11 Suppl 1:25-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. EIKE MC , Humphreys K, Becker T, Olsson M, et al
    Three microsatellites from the T1DGC MHC data set show highly significant association with type 1 diabetes, independent of the HLA-DRB1, -DQA1 and -DQB1 genes.
    Diabetes Obes Metab. 2009;11 Suppl 1:17-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. MCGINNIS R , McLaren W, Ranganath V, Whittaker P, et al
    Haplotype-based search for SNPs associated with differential type 1 diabetes risk among chromosomes carrying a specific HLA DRB1-DQA1-DQB1 haplotype.
    Diabetes Obes Metab. 2009;11 Suppl 1:8-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. BROWN WM , Pierce J, Hilner JE, Perdue LH, et al
    Overview of the MHC fine mapping data.
    Diabetes Obes Metab. 2009;11 Suppl 1:2-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. RICH SS , Nierras C, Akolkar B
    Setting the stage.
    Diabetes Obes Metab. 2009;11 Suppl 1:1.
    PubMed     Text format     Related articles   
    
    
    
94. PRATLEY RE , Kipnes MS, Fleck PR, Wilson C, et al
    Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy.
    Diabetes Obes Metab. 2009;11:167-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. FERRANNINI E , Fonseca V, Zinman B, Matthews D, et al
    Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.
    Diabetes Obes Metab. 2009;11:157-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. IDRIS I , Donnelly R
    Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug.
    Diabetes Obes Metab. 2009;11:79-88.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
97. KING AB
    Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double-blind, randomized, crossover study.
    Diabetes Obes Metab. 2009;11:69-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. KRONES R , Schutte C, Heise T
    The rapid-acting properties of insulin aspart are preserved in elderly people with type 2 diabetes.
    Diabetes Obes Metab. 2009;11:41-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. SHELDON B , Russell-Jones D, Wright J
    Insulin analogues: an example of applied medical science.
    Diabetes Obes Metab. 2009;11:5-19.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. HOLT RI
     Insulin analogues: a step forward in the care in diabetes.
     Diabetes Obes Metab. 2009;11:1-4.
     PubMed     Text format     Related articles   
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: